Visual Field Test Logo

Cost-effectiveness

بحث عميق وأدلة خبراء حول الحفاظ على صحتك البصرية.

AI for Glaucoma Detection and Prognosis: Performance, Bias, and Clinical Integration in 2025

AI for Glaucoma Detection and Prognosis: Performance, Bias, and Clinical Integration in 2025

AI for Glaucoma Detection and Prognosis: Performance, Bias, and Clinical Integration in 2025 Glaucoma is a leading cause of irreversible blindness, affecting over 90 million people worldwide (pmc.ncbi.nlm.nih.gov). Worryingly, more than 70% of glaucoma cases remain undiagnosed (pmc.ncbi.nlm.nih.gov). Early detection is crucial because vision loss from glaucoma cannot be undone. In recent years, a...

The Economics of Glaucoma Care in 2025: Screening, Devices, and Drugs

The Economics of Glaucoma Care in 2025: Screening, Devices, and Drugs

Introduction Glaucoma affects tens of millions worldwide and is the second leading cause of irreversible blindness after cataract (pmc.ncbi.nlm.nih.gov) (pmc.ncbi.nlm.nih.gov). Most cases progress silently, and roughly 3% of adults over 40 have glaucoma – the majority undiagnosed (pmc.ncbi.nlm.nih.gov). Visual loss from glaucoma heavily degrades quality of life and raises lifetime costs; one s...

هل أنت مستعد لفحص رؤيتك؟

ابدأ اختبار المجال البصري المجاني في أقل من 5 دقائق.

ابدأ الاختبار الآن

cost-effectiveness

A way to compare how much benefit a health care option gives for its cost, like treatments or screenings. It helps doctors and policymakers decide which services give the best value for improving eye health.